Neoplasms by Site
Oncology·MeSH: Neoplasms by Site
Prevalence
3358.2 / 100K
Incidence
1547.2 / 100K/yr
2 drugs in development·1 company·9 clinical trials
Drug Pipeline by Phase
Phase 4(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Neoplasms by Site?
BioSniper tracks 2 drugs in development for Neoplasms by Site across 1 company.
How many clinical trials target Neoplasms by Site?
There are 9 clinical trials targeting Neoplasms by Site tracked by BioSniper.
What is the prevalence of Neoplasms by Site?
The estimated prevalence of Neoplasms by Site is approximately 3358.2 per 100,000 population.
Deep-dive into Neoplasms by Site
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis